Skip to main content

Articles

Multiple Myeloma, Oncology
Daratumumab Added to Carfilzomib, Lenalidomide, and Dexamethasone: Safe and Tolerable in Patients with Newly Diagnosed Multiple Myeloma
Read More
Multiple Myeloma, Oncology
CAR T-Cell Immunotherapy Makes Strides in Multiple Myeloma, with Durable Remission
Read More
ASCO President Lists Progress Made in Cancer, Highlighting Current Priorities
Read More
Prostate Cancer
Abiraterone a Game-Changer in the Frontline Treatment of Metastatic Prostate Cancer
Read More
Immunotherapy, Oncology
Checkpoint Inhibitors Show Promise in Patients with Mesothelioma
Read More
FDA Approvals
FDA News - August 2017
Read More
Immunotherapy, Oncology
Pembrolizumab Makes Inroads in Sarcoma Subtypes
Read More
Leukemia, Oncology
In Chronic Myeloid Leukemia, Selection of Tyrosine Kinase Inhibitors Depends on Variables Other Than Survival
Read More
Leukemia, Oncology
ASCO 2017: Chronic Lymphocytic Leukemia Highlights
Read More
FDA Approvals
Novel Assay Provides 100 Times More Information Than Current Liquid Biopsies for Early Cancer Detection
Read More
Page 83 of 244
Results 821 - 830 of 2436